Hardbeatnews,
LOS ANGELES, CA, Fri. Oct. 21, 2005: A new study has discovered that
the deadly disease, AIDS, consistently injures the brain's motor,
language and judgment centers, but left other areas alone.
The
UCLA/University of Pittsburgh imaging study, the first of its kind,
found that AIDS is selective in how it attacks the brain and that drug
therapy does not appear to slow the damage.
“The
brain provides a sanctuary for HIV where most drugs cannot follow,"
Paul Thompson, first author and associate professor of neurology at the
David Geffen School of Medicine at UCLA, stated.
High-resolution
3-D color scans created from magnetic resonance images (MRI) vividly
illustrated the damage in the study that was published online by the
Proceedings of the National Academy of Sciences. Areas of tissue loss
glowed red and yellow, while intact regions shone blue and green.
Thompson's
laboratory used a new 3-D brain-mapping technique developed at UCLA to
analyze the MRIs of 26 people diagnosed with AIDS, and then compared
the scans to those of 14 HIV-negative people. The brain scans measured
the thickness of gray matter in various regions of the cerebral cortex.
The
University of Pittsburgh diagnosed and scanned the AIDS patients; all
26 subjects had lost at least half of their T-cells, the immune cells
targeted by HIV. None had experienced AIDS‑related dementia, and 13
were on highly active antiretroviral therapy.
"The
brain scan really catches AIDS red-handed, allowing us to see precisely
where the damage is," Thompson observed. "For the first time, we can
understand why motor skills deteriorate with AIDS, because the virus
attacks the motor centers on top of the brain."
"We
saw up to a 15-percent tissue loss in the brain centers that regulate
motor skills, such as movement and coordination," he added. "This helps
explain the slowed reflexes and disruption of balance and gait that
often affect people with early AIDS."
The
researchers were most startled to see no difference in tissue loss
between the patients taking highly active antiretroviral therapy and
those who were not.
"This
was the most terrifying aspect of our findings," Thompson said. "Even
though antiretroviral drugs rescue the immune system, AIDS is still
stalking the brain. A protective barrier prevents drugs from entering
the brain, transforming it into a reservoir where HIV can multiply and
attack cells unchecked."
The
scientists hail brain imaging as a useful method for monitoring AIDS
and evaluating new drugs' effect on disease progression. The technique
can be powerfully applied to gauge patients' response to therapy, even
before the onset of dementia or opportunistic infections.
One
in 100 people aged 15 to 49 is infected with HIV, the fourth-leading
cause of death worldwide. In 2004, 40 million people were living with
the disease. Forty percent of AIDS patients suffer from progressive
neurological symptoms, typically leading to death. The Caribbean is the
second-most affected region in the world. Among adults aged 15–44, AIDS
has become the leading cause of death. – Hardbeatnews.com